Microchimerism in Maternal-Fetal Interactions

Microchimerism refers to the long-term persistence of a small population of cells that originate from a genetically distinct individual. In the context of pregnancy, maternal microchimerism describes the presence of maternal cells in the offspring, whereas fetal microchimerism denotes the persistence of fetal cells in the mother. These cells can engraft in multiple tissues and remain detectable years after gestation, influencing immune development, tolerance mechanisms and tissue homeostasis. Their bidirectional transfer across the placenta challenges the traditional view of maternal and fetal compartments as immunologically isolated.

Accumulating evidence indicates that microchimeric cells can contribute to both protective and pathological processes. In the fetus and neonate, maternal cells may guide the maturation of immune lineages and bolster resistance to infection, while in the mother, fetal cells have been implicated in tissue repair, modulation of inflammatory responses and, in some contexts, the development of autoimmune conditions. The balance between beneficial and deleterious outcomes appears to depend on cell type, tissue localisation and the interplay with host genetic and environmental factors.

Advances in molecular detection, single-cell profiling and in vivo functional models have deepened our understanding of trafficking routes, cellular phenotypes and signalling pathways that govern microchimerism. Insights into chemokine-driven recruitment and antigen-driven retention underscore the potential for therapeutic exploitation, from augmenting wound healing to refining transplantation monitoring. Given its ubiquity across mammalian species and relevance to human health, microchimerism represents a frontier for translational research with global significance.

Research from Nature Portfolio

A seminal study demonstrated that maternal immune cells transferred in utero can shape neonatal defence by promoting differentiation of fetal haematopoietic stem cells towards monocyte lineages, thereby enhancing resilience against viral challenge in early life. This work revealed a direct link between maternal cell load in cord blood and reduced incidence of respiratory infection during infancy, emphasising a protective role for microchimerism in human health. Another foundational investigation identified a subset of fetal microchimeric cells bearing chemokine receptor Ccr2 that are mobilised to sites of maternal injury via Ccl2 signalling. These cells transdifferentiate into endothelial progenitors, promote angiogenesis and accelerate wound closure in pregnant and postpartum models, illustrating a natural stem-cell therapy mechanism that could inspire novel regenerative strategies.

Microchimerism in Maternal-Fetal Interactions publication trend

The graph below shows the total number of articles in microchimerism in maternal-fetal interactions across all publications each year (not limited to Nature Index journals).

Technical terms

Microchimerism: The coexistence of genetically distinct cell populations within a single individual, arising from cell transfer during pregnancy or transplantation.

Maternal microchimerism: Maternal cells that engraft and persist in the offspring following transplacental cell trafficking during gestation.

Fetal microchimerism: Fetal cells that infiltrate maternal tissues and remain detectable long after childbirth.

Ccl2/Ccr2 signalling: A chemokine and its receptor mediating recruitment of microchimeric cells to sites of injury or inflammation.

Regulatory T cell (Treg): A specialised CD4+ T-cell subset that maintains immune tolerance and prevents excessive inflammatory responses.

References

1. Vertically transferred maternal immune cells promote neonatal immunity against early life infections. Nature Communications (2021).
2. Ccl2/Ccr2 signalling recruits a distinct fetal microchimeric population that rescues delayed maternal wound healing. Nature Communications (2017).
3. Quantification of Female Chimeric Cells in the Tonsils of Male Children and Their Determinants. Cells (2023).
4. Factors influencing maternal microchimerism throughout infancy and its impact on infant T cell immunity. Journal of Clinical Investigation (2022).
5. Characterization of fetal microchimeric immune cells in mouse maternal hearts during physiologic and pathologic pregnancies. Frontiers in Cell and Developmental Biology (2023).